CIK: 0001012622 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 14, 2017
Total Value ($000): $602,930 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | TESARO INC | 1,248,086 | $167,843 | 27.8% | $12810.39 | — | COM | 881569107 |
| — | ACCELERATE DIAGNOSTICS INC | 5,032,389 | $104,422 | 17.3% | $24998.12 | — | COM | 004304200 |
| — | NXSTAGE MEDICAL INC | 2,721,636 | $71,334 | 11.8% | $12876.33 | — | COM | 67072V103 |
| — | MAZOR ROBOTICS LTD | 2,719,942 | $59,621 | 9.9% | $11234.47 | — | SPONSORED ADS | 57886P103 |
| — | QUIDEL CORP | 2,517,554 | $53,926 | 8.9% | $25530.00 | — | COM | 74838J101 |
| OPK | OPKO HEALTH INC | 3,534,539 | $32,871 | 5.5% | $7.38 | +40.2% | COM | 68375N103 |
| — | AMARIN CORP PLC | 7,935,000 | $24,440 | 4.1% | $680.25 | — | SPONS ADR NEW | 023111206 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 5,516,894 | $20,964 | 3.5% | $5.80 | +25.3% | COM | 69404D108 |
| — | BIOLASE INC | 14,622,050 | $20,471 | 3.4% | $1097.01 | — | COM | 090911108 |
| — | INTREXON CORP | 820,590 | $19,940 | 3.3% | $4275.17 | — | COM | 46122T102 |
| — | VERMILLION INC | 8,624,225 | $8,193 | 1.4% | $1646.88 | — | COM NEW | 92407M206 |
| — | AGENUS INC | 1,925,918 | $7,935 | 1.3% | $986.80 | — | COM | 00847G101 |
| ARAY | ACCURAY INC | 1,490,879 | $6,858 | 1.1% | $5.71 | -9.1% | COM | 004397105 |
| — | CONTRAFECT CORP | 1,182,032 | $2,069 | 0.3% | $5.25 | — | COM | 212326102 |
| BIIB | BIOGEN INC | 6,723 | $1,907 | 0.3% | $213.68 | +38.7% | COM | 09062X103 |
| — | SECOND SIGHT MED PRODS INC | 50,804 | $100 | 0.0% | $10.26 | — | COM | 81362J100 |
| — | ZIOPHARM ONCOLOGY INC | 6,661 | $36 | 0.0% | $12.00 | — | COM | 98973P101 |